UQÀM, UMontréal projects receive funding for cancer treatment, prevention

Several research and development projects led by Université du Québec à Montréal and the Université de Montréal have received support and funding to advance cancer treatment and prevention. The Québec Consortium for Drug Discovery (CQDM), supported by a grant from the Government of Québec, recently announced its support for three innovative projects that work with biopharmaceutical companies to fight cancer, two of which are led by postsecondary institutions. UQÀM will work with Theratechnologies and Mitacs on a $7.9M project that aims to mitigate the side effects associated with chemotherapy, while a $3.45M project led by UMontréal, the McGill University Health Centre, and Saydi Biotech will investigate a new genetically targeted therapy focused on cancer eradication.